Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25190069 | 0.83 | GPR35 (0.53) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL9452233 | 0.81 | GPR35 (0.61) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL25190368 | 0.81 | CDC25C (0.46) | GPR35HTTSMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL25199860 | 0.80 | GPR35 (0.47) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL25190113 | 0.78 | GPR35 (0.48) | GPR35HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL25188801 | 0.78 | GPR35 (0.50) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL25183606 | 0.77 | GPR35 (0.47) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL27979430 | 0.77 | GPR35 (0.56) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL25200927 | 0.76 | GPR35 (0.46) | GPR35HTTMEN1KMT2AGALR3 | |
| SCHEMBL25190096 | 0.76 | GPR35 (0.46) | GPR35HTTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325547-A1 | ANTI-SARS-COV-2 DRUG | KAGOSHIMA UNIVERSITY (JP) | 2025-10-23 | — | — | US | disclosed |
| EP-4431151-A1 | ANTI-SARS-COV-2 DRUG | Kagoshima University (JP) | 2024-09-18 | — | — | EP | disclosed |
| CN-118302413-A | Anti-SARS-CoV-2 medicine | 国立大学法人鹿儿岛大学 | 2024-07-05 | — | — | CN | disclosed |
| WO-2023085392-A1 | ANTI-SARS-COV-2 DRUG | 国立大学法人鹿児島大学 | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325547-A1 | ANTI-SARS-COV-2 DRUG | ACE2, ACE, AGTR2 | GPR35 1908/4885HTT 1537/4885MEN1 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.